Pune-based Serum Institute of India will produce the Russia-developed-vaccine Sputnik V from September. The Russian Direct Investment Fund (RDIF) said they have planned to produce over...
At 91.6%, Sputnik V has a higher efficacy compared to the two vaccines that are currently being administered in India - Oxford-AstraZeneca's Covishield, manufactured by the...
Third stage trials of the Russian Sputnik V vaccine for coronavirus can begin in India within the next few weeks once the regulatory clearances are in.